Focal One
@FocalOneHIFU
Followers
376
Following
160
Statuses
303
Focal One is the first and only robotic platform designed for focal ablation of prostate tissue using High Intensity Focused Ultrasound (HIFU)
Joined January 2022
Our team is growing! We're looking for Clinical Applications Specialists in the Northern California and Chicago regions. If you're interested in joining the @FocalOneHIFU team or exploring other opportunities, visit #FocalOne | #Hiring | #Cancer | #ProstateCancer | #Urology | #MedTech
0
0
1
The Robotic Positioning System of the @FocalOneHIFU device utilizes motorized movements with submillimetric accuracy along 5 degrees of freedom, executing targeted ablation. Its automatic safety features preserve precision and protection of the rectal wall with each lesion firing. Discover more about the Focal One platform here: #FocalOneFriday | #Cancer | #ProstateCancer | #Urology | #MedTech
0
0
3
RT @FUSFoundation: Results from a multicenter study comparing high-intensity focused ultrasound (HIFU) with radical prostatectomy surgery w…
0
3
0
Congratulations to @Putnam_Cole and the clinical staff from @BWHUrology for treating their 50th patient with @FocalOneHIFU! This is a significant milestone and highlights Brigham and Women's commitment to advancing prostate cancer patient care. #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech
0
0
2
@FocalOneHIFU is the leading non-invasive, non-surgical option for the ablation of prostate tissue in the management of prostate cancer. Our technology targets prostate tissue by focusing high-intensity focused ultrasound (HIFU) waves on the affected area, resulting in a localized effect targeting only the diseased portion of the prostate without damaging healthy surrounding tissue and critical structures. There is no incision, no blood loss, and no radiation leading to minimal side effects and better quality of life. To learn more, visit #FocalOneFriday | #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech
0
3
9
RT @UCD_Cancer: .@UCD_Cancer is offering a non-invasive prostate cancer procedure without a blade, incision, scar, or radiation, called hig…
0
3
0
We're proud that @KuakiniHealth is a part of our global community, offering @FocalOneHIFU in Hawaii as an option for prostate cancer patients. Visit to learn more about the HIFI Study, which is the largest prospective, comparative, multicenter study ever conducted on prostate cancer treatments. It demonstrates that Focal One Robotic HIFU provided comparable cancer control while maintaining quality of life for patients with prostate cancer when compared to surgery. #Cancer | #ProstateCancer | #Urology | #MedTech | #ClinicalStudy | #ProstateCancerStudy | #HIFIStudy
@KuakiniHealth offers @FocalOneHIFU as a treatment for patients living with prostate cancer, and a recent study discovered that HIFU treatments have a lower negative impact on functional outcomes than surgical options. Read more: #KuakiniHealthSystem
1
1
4
RT @RubenOlivaresG: Congratulations to @drjkaouk on being named Chair of Urology at @CleClinicUro ! A true innovator and an authentic team…
0
4
0
@FocalOneHIFU's Dynamic Focusing Technology delivers accurate HIFU energy in 5mm increments up to 40mm in anterior to posterior length, with high resolution real-time ultrasound imaging. This approach emphasizes higher precision, allowing the urologist to contour and ablate the targeted lesion while avoiding critical structures. Find out more on our website: #FocalOneFriday | #Cancer | #ProstateCancer | #Urology | #MedTech
1
2
4
@FocalOneHIFU CEO, Ryan Rhodes, discusses the impact of the HIFI Study, a landmark clinical trial in prostate cancer treatment comparing Robotic HIFU vs. Radical Prostatectomy. “[The study] is all about patient access,” Rhodes said. “Patients need access to new technologies that treat the disease and improve quality-of-life outcomes. So what I think is most exciting, the study allows us to get in front of not only patients themselves, but [also the] urologists who treat these prostate cancer patients, the hospitals that offer point-of-care services, and even the payers that pay for treatment.” Read the rest of Ryan Rhodes' interview here: #Cancer | #ProstateCancer | #Urology | #MedTech | #ClinicalStudy | #ProstateCancerStudy | #HIFIStudy
0
2
3
The HIFI Study is the largest prospective clinical study ever conducted comparing localized prostate cancer treatments. The study enrolled a total of 3,328 patients across 46 centers, including 1,967 consecutive HIFU patients and 1,361 Radical Prostatectomy (RP) patients. 90% of the HIFU patients in the study were treated with our latest generation @FocalOneHIFU technology. Of those patients treated with HIFU, 90% were free from Salvage Treatment compared to 86% of those who underwent RP. To learn more, visit #Cancer | #ProstateCancer | #Urology | #MedTech | #ClinicalStudy | #ProstateCancerStudy | #HIFIStudy
0
2
4
RT @UCD_Cancer: .@UCD_Cancer is offering a non-invasive prostate cancer procedure without a blade, incision, scar, or radiation, called hig…
0
6
0
Cheers to 2024, a year filled with spirited collaboration, notable achievements, and significant milestones! We look forward to reaching new heights as a company and further advancing @FocalOneHIFU as the leading technology for the management of prostate cancer in the coming year. Wishing you all a Happy New Year and a wonderful 2025!
0
2
3
May your holiday season be filled with joy and cheer! Happy Holidays from our @FocalOneHIFU family to yours!
1
1
3
In September of 2023, Bill Sedivy's prostate cancer came back after initially being treated with radiation. After consulting with his Urologic Oncologist, @ZSchwen, MD, from @CleClinicUro, Bill was treated with @FocalOneHIFU, a non-invasive, nonsurgical option for the management of prostate cancer. Compared to other surgeries, Zeyad Schwen, MD said, there’s “less sexual and urinary side effects as well as a much quicker recovery time" when discussing @FocalOneHIFU. Bill Sedivy's quality of life and passion for the outdoors were two factors he considered when he had to get treated for his prostate cancer again. One month after his procedure, Bill was well enough to travel to Costa Rica. Read more about Bill's story below! #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech
“Salvage HIFU is a promising newer option for people who have had a recurrence in their prostate,” explains @ZSchwen | Salvage HIFU: Saving the Prostate After Recurrence
0
0
2
The HIFI Study is the largest prospective, comparative, multi-center study ever completed evaluating oncologic and functional outcomes of localized prostate cancer treatments: Robotic HIFU vs. Radical Prostatectomy. It demonstrates that @FocalOneHIFU provided comparable cancer control while maintaining quality of life for patients with prostate cancer when compared to surgery. To learn more, visit: #Cancer | #ProstateCancer | #Urology | #MedTech | #ClinicalStudy | #ProstateCancerStudy | #HIFIStudy
1
2
3
RT @UrologyTimes: Data from the prospective HIFI trial have been published in European Urology, showing that HIFU achieved a noninferior sa…
0
2
0
Join @NitinYerram, MD, James Wysock, MD, and George Schade, MD (@schadegr) on December 11 for an exclusive webinar on the advances in Focal One HIFU techniques and treatment planning. The discussion will cover optimizing patient selection, what is second pass, pre-surgical planning, utilizing HIFUsion for treatment optimization, and utilizing real-time intraoperative imaging. Click here to register: #Cancer | #RoboticSurgery | #Urology | #ProstateCancer | #MedTech
0
1
1